Organizations shaping AI

Isomorphic Labs

Alphabet drug-discovery company spun out of DeepMind, applying AlphaFold-style AI to pharmaceutical research.

Insilico Medicine

Drug-discovery company applying generative AI to longevity and disease research.

Absci

Combines generative models with proprietary biological data and laboratory validation to design new protein-based medicines, including antibodies against targets that conventional discovery methods struggle to address.

Aithyra brings machine learning, experimental biology and automated laboratories together to accelerate biomedical discovery. Its research spans molecular and protein design, cell biology, virology and systems that can plan and run scientific experiments.

Atomic AI

Biotechnology company combining machine learning, structural biology, and experimental assays to predict RNA structure and develop RNA-targeted medicines.

Denali Therapeutics is a biotechnology company developing medicines for serious diseases affecting the brain and body. Its work centers on barrier-crossing biologics, including its TransportVehicle platform for delivering therapies across biological barriers such as the blood-brain barrier.

Generate:Biomedicines

Biotechnology company developing protein therapeutics through an integrated platform that combines machine learning, biological engineering, and automated experimentation.

Global biopharmaceutical company focused on vaccines, specialty medicines, and general medicines.

insitro

Drug-discovery company applying machine learning to biology, founded by Daphne Koller.

Contract research organization providing drug discovery and development services to biopharmaceutical companies.

Biotechnology company developing diagnostics and drug programs for persistent microbial infections implicated in chronic disease.

Recursion

Recursion Pharmaceuticals is an AI drug-discovery company headquartered in Salt Lake City founded by Chris Gibson and others. It pairs automated cell imaging with machine learning to identify drug candidates (NASDAQ: RXRX).

Atomwise is a San Francisco-based drug discovery company that applies deep learning to molecular screening to identify drug candidates for diseases.